Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1 mouse model
Paola Verachi(University of Bologna), Anna Ritá Migliaccio(Altius Institute for Biomedical Sciences)
Cited by 8
Related Papers
The Variation in the Traits Ameliorated by Inhibitors of JAK1/2, TGF-β, P-Selectin, and CXCR1/CXCR2 in the Gata1low Model Suggests That Myelofibrosis Should Be Treated by These Drugs in Combination
|International Journal of Molecular Sciences|2024|4